OTC healthcare in Belgium
1. EXECUTIVE SUMMARY
2. OPERATING ENVIRONMENT
2.1 OTC Registration and Classification
2.2 Vitamins & Dietary Supplements Registration and Classification
2.3 Advertising
2.4 Packaging and Labelling
2.5 Distribution
2.6 De-listing or De-reimbursement
2.7 Traditional Remedies
2.8 Homeopathy
2.9 Generics
2.10 Consumer Expenditure on Health Goods and Medical Services
Table 1 Consumer Expenditure on Health Goods and Medical Services 2001-2003
Table 2 Consumer Expenditure on Health Goods and Medical Services 1999-2004
2.11 Life Expectancy
Table 3 Life Expectancy at Birth 1999-2004
3. OTC HEALTHCARE SALES
3.1 Market Performance
Table 4 Sales of OTC Healthcare by Sector: Value 1999-2004
Table 5 Sales of OTC Healthcare by Sector: % Value Growth 1999-2004
3.2 Switches
Summary 1 OTC Healthcare Switches 2003-2004
3.3 Competitive Environment
Table 6 OTC Healthcare Company Shares 2001-2004
Table 7 OTC Healthcare Brand Shares 2001-2004
3.4 Leading Company Profiles: Janssen-Cilag NV
Summary 2 Janssen-Cilag Operational Indicators 2003
Summary 3 Janssen-Cilag SA Production Statistics 2003
3.5 Leading Company Profiles: Omega Pharma
Summary 4 Omega Pharma Operational Indicators 2003
Summary 5 Omega Pharma Production Statistics 2003
3.6 Leading Company Profiles: Procter & Gamble Pharmaceutical NV SA
Summary 6 Procter & Gamble Operational Indicators 2003
Summary 7 Procter & Gamble Production Statistics 2003
3.7 Leading Company Profiles: Sanofi-Aventis
Summary 8 Sanofi-Aventis Operational Indicators 2003
Summary 9 Sanofi-Aventis Production Statistics 2003
3.8 Retail Distribution
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 1999/2004
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2004
3.9 Retailer Activity and Private Label Trends
Table 10 Penetration of Private Label by Sector 2001-2004
3.10 Forecast Market Performance
Table 11 Forecast Sales of OTC Healthcare by Sector: Value 2004-2009
Table 12 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2004-2009
4. WOUND TREATMENTS SALES
4.1 Sector Performance
Table 13 Sales of Wound Treatments by Subsector: Value 1999-2004
Table 14 Sales of Wound Treatments by Subsector: % Value Growth 1999-2004
Table 15 Wound Treatments Company Shares 2001-2004
Table 16 Wound Treatments Brand Shares 2001-2004
Table 17 Forecast Sales of Wound Treatments by Subsector: Value 2004-2009
Table 18 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2004-2009
Summary 10 Wound Treatments: New Product Launches 2003-2004
5. OTHER OTC
6. DEFINITIONS
